Payment overview · 2025
General Payments
$24.87
1 reported records · 1 companies
Healthcare provider profile · identity verified
Christopher K Jenkins, DO
Allopathic & Osteopathic Physicians|Emergency Medicine · WALLA WALLA, WA · NPI 1962495994
Verified facts
What the public records show
CMS Open Payments records show Christopher K Jenkins, DO received $24.87 in general payments during 2025 across 1 reported records.
Philips North America LLC accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Philips North America LLC | Unresolved — no canonical attribution shown | $24.87 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $24.87 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ambulatory Monitoring & Diagnostics Undivided Normalized: ambulatory monitoring diagnostics undivided |
Device | Philips North America LLC | $24.87 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 580 | 132 |
| Eliquis | Apixaban | 426 | 66 |
| Levothyroxine Sodium | Levothyroxine Sodium | 405 | 85 |
| Gabapentin | Gabapentin | 282 | 63 |
| Furosemide | Furosemide | 271 | 65 |
| Tamsulosin Hcl | Tamsulosin Hcl | 230 | 45 |
| Pantoprazole Sodium | Pantoprazole Sodium | 219 | 35 |
| Potassium Chloride | Potassium Chloride | 210 | 48 |
| Lisinopril | Lisinopril | 189 | 59 |
| Amlodipine Besylate | Amlodipine Besylate | 168 | 38 |
| Metoprolol Succinate | Metoprolol Succinate | 165 | 58 |
| Metformin Hcl | Metformin Hcl | 154 | 30 |
| Finasteride | Finasteride | 148 | 27 |
| Jardiance | Empagliflozin | 147 | 22 |
| Losartan Potassium | Losartan Potassium | 146 | 39 |
| Omeprazole | Omeprazole | 134 | 34 |
| Metoprolol Tartrate | Metoprolol Tartrate | 118 | 30 |
| Allopurinol | Allopurinol | 115 | 19 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 110 | 12 |
| Duloxetine Hcl | Duloxetine Hcl | 101 | 32 |
| Clopidogrel | Clopidogrel Bisulfate | 100 | 28 |
| Xarelto | Rivaroxaban | 99 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 97 | 21 |
| Ondansetron Hcl | Ondansetron Hcl | 90 | 18 |
| Sertraline Hcl | Sertraline Hcl | 90 | 25 |
| Baclofen | Baclofen | 88 | 15 |
| Levetiracetam | Levetiracetam | 87 | 15 |
| Famotidine | Famotidine | 81 | 18 |
| Escitalopram Oxalate | Escitalopram Oxalate | 80 | 19 |
| Fluoxetine Hcl | Fluoxetine Hcl | 78 | 19 |
| Trazodone Hcl | Trazodone Hcl | 75 | 21 |
| Buspirone Hcl | Buspirone Hcl | 72 | 13 |
| Carvedilol | Carvedilol | 70 | 17 |
| Mirtazapine | Mirtazapine | 67 | 20 |
| Donepezil Hcl | Donepezil Hcl | 64 | 14 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 64 | 14 |
| Bupropion Xl | Bupropion Hcl | 60 | 15 |
| Latanoprost | Latanoprost | 60 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 58 | 23 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 53 | 17 |
| Amiodarone Hcl | Amiodarone Hcl | 52 | 12 |
| Hydrochlorothiazide | Hydrochlorothiazide | 52 | suppressed |
| Spironolactone | Spironolactone | 50 | 18 |
| Digoxin | Digoxin | 49 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 47 | 12 |
| Metformin Hcl Er | Metformin Hcl | 47 | 12 |
| Warfarin Sodium | Warfarin Sodium | 47 | suppressed |
| Bumetanide | Bumetanide | 46 | suppressed |
| Entresto | Sacubitril/Valsartan | 46 | 11 |
| Lamotrigine | Lamotrigine | 45 | suppressed |
| Aripiprazole | Aripiprazole | 43 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 43 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 41 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 40 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 40 | 16 |
| Citalopram Hbr | Citalopram Hydrobromide | 38 | 12 |
| Januvia | Sitagliptin Phosphate | 38 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 37 | 12 |
| Simvastatin | Simvastatin | 36 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 34 | suppressed |
| Glipizide | Glipizide | 34 | suppressed |
| Lorazepam | Lorazepam | 34 | 11 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 32 | suppressed |
| Olanzapine | Olanzapine | 32 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 31 | 16 |
| Ondansetron Odt | Ondansetron | 31 | 18 |
| Oxycodone Hcl | Oxycodone Hcl | 31 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 30 | suppressed |
| Haloperidol | Haloperidol | 28 | suppressed |
| Primidone | Primidone | 28 | suppressed |
| Lansoprazole | Lansoprazole | 27 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 26 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 26 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 26 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 26 | suppressed |
| Cefdinir | Cefdinir | 25 | 18 |
| Diclofenac Sodium | Diclofenac Sodium | 25 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 24 | suppressed |
| Levofloxacin | Levofloxacin | 23 | suppressed |
| Nystatin | Nystatin | 23 | 14 |
| Risperidone | Risperidone | 23 | suppressed |
| Torsemide | Torsemide | 23 | 12 |
| Incruse Ellipta | Umeclidinium Bromide | 22 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 22 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 21 | 18 |
| Prednisone | Prednisone | 21 | 11 |
| Spiriva Handihaler | Tiotropium Bromide | 20 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 20 | suppressed |
| Trulicity | Dulaglutide | 20 | suppressed |
| Fentanyl | Fentanyl | 19 | suppressed |
| Cephalexin | Cephalexin | 18 | suppressed |
| Restasis | Cyclosporine | 18 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Myrbetriq | Mirabegron | 17 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 17 | suppressed |
| Atenolol | Atenolol | 16 | suppressed |
| Lactulose | Lactulose | 16 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 16 | suppressed |
| Sucralfate | Sucralfate | 16 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 15 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 15 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 15 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 15 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 15 | suppressed |
| Clozapine | Clozapine | 14 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 14 | suppressed |
| Ezetimibe | Ezetimibe | 14 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 14 | suppressed |
| Letrozole | Letrozole | 14 | suppressed |
| Memantine Hcl | Memantine Hcl | 14 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 14 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 14 | suppressed |
| Tiotropium Bromide | Tiotropium Bromide | 14 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 13 | suppressed |
| Calcitriol | Calcitriol | 13 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 13 | suppressed |
| Lithium Carbonate Er | Lithium Carbonate | 13 | suppressed |
| Metronidazole | Metronidazole | 13 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 13 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 13 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 13 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 13 | suppressed |
| Timolol Maleate | Timolol Maleate | 13 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 12 | suppressed |
| Celecoxib | Celecoxib | 12 | suppressed |
| Dulera | Mometasone/Formoterol | 12 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 12 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 12 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 12 | suppressed |
| Novolog Flexpen | Insulin Aspart | 12 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 12 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Amoxicillin | Amoxicillin | 11 | suppressed |
| Clonidine | Clonidine | 11 | suppressed |
| Creon | Lipase/Protease/Amylase | 11 | suppressed |
| Dantrolene Sodium | Dantrolene Sodium | 11 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 11 | suppressed |
| Fiasp | Insulin Aspart (Niacinamide) | 11 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 11 | suppressed |
| Mounjaro | Tirzepatide | 11 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 11 | suppressed |
| Ozempic | Semaglutide | 11 | suppressed |
| Paroxetine Er | Paroxetine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $24.87 · 1 records | Philips North America LLC | Ambulatory Monitoring & Diagnostics Undivided | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error